# Formulated PSTA Injection Versus PATA Alone in the Management of Macular Edema Secondary to Non-ischemic Retinal Vein Occlusions

> **NCT05385562** · NA · COMPLETED · sponsor: **Al-Azhar University** · enrollment: 78 (actual)

## Conditions studied

- Macula Edema

## Interventions

- **DRUG:** Triamcinolone Acetonide and sodium hyaluronate and chondroitin sulfate
- **DRUG:** Triamcinolone Acetonide alone

## Key facts

- **NCT ID:** NCT05385562
- **Lead sponsor:** Al-Azhar University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-02
- **Primary completion:** 2022-05-01
- **Final completion:** 2022-05-10
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2022-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05385562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05385562, "Formulated PSTA Injection Versus PATA Alone in the Management of Macular Edema Secondary to Non-ischemic Retinal Vein Occlusions". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05385562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*